The Net Margin of Gensight Biologics SA (SIGHT.PA) is -933.40%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -933.40% |
| 2023-12-31 | -2069.53% |
| 2022-12-31 | -1069.91% |
| 2021-12-31 | -542.40% |
| 2020-12-31 | -774.12% |
| 2019-12-31 | -4409.86% |